Untitled Document
Prostate Cancer is the second most common cancer in men. Though the five year survival rate is relatively high, prostate cancer is still the second cause of cancer related death after lung cancer for men in many western countries.
The treatment plan is developed from one’s age, general health condition, stage, and grade of cancer and side effects with treatment. Expectant management or watchful waiting is recommended if the patient is old or has other serious health condition and if the tumor is localized and has no symptoms since prostate cancer often grows very slowly. If the prostate tumor grows more quickly or causes symptoms, active treatments will be suggested.
Traditional Treatments include Surgery, Radiotherapy, Chemotherapy, and Hormone Therapy
Cutting-edge therapies available in Cancer Therapy China (CTC) for prostate cancer may consist some of:
Traditional Treatments include Surgery, Radiotherapy, Chemotherapy, and Hormone Therapy
Cutting-edge therapies available in Cancer Therapy China (CTC) for prostate cancer may consist some of:
For early stage prostate cancer,
- Surgery
- Hormone therapy
- CIK-DC immunotherapy
Features:
- Efficient prevention of recurrence and metastasis
- Good quality of life
For advanced prostate cancer,
- Cryoablation
- Gentle chemotherapy
- Gene therapy
- Antiangionesis therapy
- Hormone therapy
- CIK-DC cell immunotherapy
Features:
- Low toxicity or side effects to human body.
- Minimally invasive cryoablation, with little harm to normal function and little pains to patients, small incision and quick recovery.
- Significantly extends survival time with a good quality of life
